Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Blood (2018) 132 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2018-99-118507

Published: 2018

Journal Articles

Identification of SETBP1 As an Epigenetic Hub Protein That Induces the Transcription of a Network of Development-Related Genes

Blood (2017) 130 (Supplement 1): 4980.

https://doi.org/10.1182/blood.V130.Suppl_1.4980.4980

Published: 2017

Journal Articles

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

Alessandra Trojani, Milena Lodola, Barbara Di Camillo, Giuseppe Rossi, MD, Adele Capucci, Alessandra Perego, Enrico Maria Pogliani, MD, Ester Orlandi, MD, Alessandra Iurlo, MD PhD, Simona Malato, Paolo Corradini, MD, Roberto Cairoli, Marco Bregni, Salvatore Artale, Enrica Morra, Ester Pungolino, MD

Blood (2014) 124 (21): 5177.

https://doi.org/10.1182/blood.V124.21.5177.5177

Published: 2014

Journal Articles

Microarray of Bone Marrow CD34+/Lin- Cells from Patients with Chronic Myeloid Leukemia (CML)

Blood (2014) 124 (21): 5178.

https://doi.org/10.1182/blood.V124.21.5178.5178

Published: 2014

Journal Articles

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Benedetta Mazzi, BSc, Roberto Crocchiolo, MD, Didier Blaise, MD, Lisbeth Barkholt, MD, Jacques-Olivier Bay, MD, PhD, Rocco Pastano, MD, Margherita Torchio, PhD, Stefania Trinca, DM, Jacopo Peccatori, MD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Marco Bregni, MD

Blood (2012) 120 (21): 4667.

https://doi.org/10.1182/blood.V120.21.4667.4667

Published: 2012

Journal Articles

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

Raffaella Fontana, Marco Bregni, Arcadi Cipponi, Laura Raccosta, Cristina Rainelli, Daniela Maggioni, Francesca Lunghi, Fabio Ciceri, Sylvain Mukenge, Claudio Doglioni, Didier Colau, Pierre G. Coulie, Claudio Bordignon, Catia Traversari, Vincenzo Russo

Blood (2009) 113 (8): 1651–1660.

https://doi.org/10.1182/blood-2008-07-168666

Published: 2009

Includes: Supplemental data

Journal Articles

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse of Malignant Disease: Retrospective Analysis of Outcome and Predictive Factors

Tapani Ruutu, Ronald Brand, Anja van Biezen, Vanderson Rocha, Anna Sureda, André Tichelli, Hermann Einsele, Giorgio Dini, Marco Bregni, Laurent Garderet, Jane Apperley, Alois Gratwohl, Dietger Niederwieser, Theo de Witte

Blood (2008) 112 (11): 339.

https://doi.org/10.1182/blood.V112.11.339.339

Published: 2008

Journal Articles

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Blood (2008) 112 (11): 353.

https://doi.org/10.1182/blood.V112.11.353.353

Published: 2008

Journal Articles

Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation

Fabio Ciceri, Chiara Bonini, Sarah Marktel, Elisabetta Zappone, Paolo Servida, Massimo Bernardi, Alessandra Pescarollo, Attilio Bondanza, Jacopo Peccatori, Silvano Rossini, Zulma Magnani, Monica Salomoni, Claudia Benati, Maurilio Ponzoni, Luciano Callegaro, Paolo Corradini, Marco Bregni, Catia Traversari, Claudio Bordignon

Blood (2007) 109 (11): 4698–4707.

https://doi.org/10.1182/blood-2006-05-023416

Published: 2007

Journal Articles

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT.

Blood (2006) 108 (11): 307.

https://doi.org/10.1182/blood.V108.11.307.307

Published: 2006

Journal Articles

Matched Unrelated Donor Stem Cell Transplantation for Patients with Diffuse Large Cell B Cell Lymphoma: A Retrospective Analysis of 118 Patients Registered through the European Group for Blood and Marrow Transplantation (EBMT).

Irit Avivi, MD, PhD, Carme Canals, MD, Goli Taghipour, Dietger Niederwieser, MD, PhD, Lothar Kanz, MD, PhD, Gerhard Ehninger, MD, PhD, Jurgen Finke, MD, PhD, Hildegard T. Greinix, MD, PhD, Arnon Nagler, MD, PhD, Jean Paul Vernant, MD, PhD, Sebastien Maury, MD, PhD, Marco Bregni, MD, PhD, Werner Linkesch, MD, PhD, Rainer Schwerdtfeger, MD, PhD, Anna Sureda, MD

Blood (2006) 108 (11): 602.

https://doi.org/10.1182/blood.V108.11.602.602

Published: 2006

Journal Articles

Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function

Rita Clementi, Annalisa Chiocchetti, Giuseppe Cappellano, Elisa Cerutti, Massimo Ferretti, Elisabetta Orilieri, Irma Dianzani, Marina Ferrarini, Marco Bregni, Cesare Danesino, Valeria Bozzi, Maria Caterina Putti, Franco Cerutti, Angela Cometa, Franco Locatelli, Rita Maccario, Ugo Ramenghi, Umberto Dianzani

Blood (2006) 108 (9): 3079–3084.

https://doi.org/10.1182/blood-2006-02-001412

Published: 2006

Journal Articles

Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation (allo-SCT) Is an Effective Salvage Treatment for Peripheral T-Cell Non-Hodgkin’s Lymphoma (PTCL).

Paolo Corradini, MD, Anna Dodero, MD, Marco Bregni, MD, Francesco Zallio, MD, Lucia Farina, MD, Alessandro Rambaldi, MD, Francesca Patriarca, MD, Attilio Olivieri, MD, Francesca Bonifazi, MD, Alessandro Massimo Gianni, MD, Corrado Tarella, MD

Blood (2005) 106 (11): 1128.

https://doi.org/10.1182/blood.V106.11.1128.1128

Published: 2005

Journal Articles

Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Stem Cell Transplantation (SCT) for Relapsed Lymphomas: Impact of Pre-Transplantation Factors on Long-Term Outcome.

Paolo Corradini, MD, Anna Dodero, MD, Marco Bregni, MD, Fabio Ciceri, MD, Attilio Olivieri, MD, Lucia Farina, MD, Pinuccia Valagussa, MD, Rosanna Scime’, MD, Anna Locasciulli, MD, Francesca Patriarca, MD, Alessandro Massimo Gianni, MD, Corrado Tarella, MD

Blood (2005) 106 (11): 1129.

https://doi.org/10.1182/blood.V106.11.1129.1129

Published: 2005

Journal Articles

High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL ( Gruppo Italiano Terapie Innovative nei Linfomi ).

Corrado Tarella, MD, Manuela Zanni, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Claudia Castellino, MD, Alessandra Pescarollo, MD, Valerio Zoli, MD, Daniele Caracciolo, MD, Marco Ladetto, MD, Michele Magni, MD, Liliana Devizzi, MD, Mario Boccadoro, MD, Marco Bregni, MD, Paolo Corradini, MD, Andrea Gallamini, MD, Ignazio Majolino, MD, Salvo Mirto, MD, Alessandro M. Gianni, MD

Blood (2005) 106 (11): 2068.

https://doi.org/10.1182/blood.V106.11.2068.2068

Published: 2005

Journal Articles

Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.

Luca Vago, MD, Simona Di Terlizzi, BS, Elisabetta Zino, BS, Chiara F. Magnani, BS, Maria T. Lupo Stanghellini, MD, Zulma Magnani, PhD, Benedetta Mazzi, BS, Daniela Clerici, MD, Attilio Bondanza, MD, Marco Bregni, MD, Silvano Rossini, MD, Jacopo Peccatori, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2005) 106 (11): 2905.

https://doi.org/10.1182/blood.V106.11.2905.2905

Published: 2005

Journal Articles

A proportion of patients with lymphoma may harbor mutations of the perforin gene

Rita Clementi, Franco Locatelli, Loïc Dupré, Alberto Garaventa, Lorenzo Emmi, Marco Bregni, Graziella Cefalo, Antonia Moretta, Cesare Danesino, Margherita Comis, Andrea Pession, Ugo Ramenghi, Rita Maccario, Maurizio Aricò, Maria Grazia Roncarolo

Blood (2005) 105 (11): 4424–4428.

https://doi.org/10.1182/blood-2004-04-1477

Published: 2005

Journal Articles

Patients with Lymphoma May Harbor Mutations of the Perforin Gene.

Rita Clementi, M.D., Franco Locatelli, M.D., Loic Dupre, PhD, Alberto Garaventa, M.D., Lorenzo Emmi, M.D., Marco Bregni, M.D., Graziella Cefalo, M.D., Antonia Moretta, PhD, Cesare Danesino, M.D., Margherita Comis, M.D., Andrea Pession, M.D., Ugo Ramenghi, M.D., Rita Maccario, PhD, Maurizio Arico’, M.D., Maria Grazia Roncarolo, M.D.

Blood (2004) 104 (11): 1358.

https://doi.org/10.1182/blood.V104.11.1358.1358

Published: 2004

Journal Articles

Inherited Perforin and Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma.

Rita Clementi, Lorenzo Dagna, Umberto Dianzani, Loic Dupre, Irma Dianzani, Fabio Ciceri, Rita Maccario, Franco Locatelli, Cesare Danesino, Marina Ferrarini, Marco Bregni

Blood (2004) 104 (11): 1379.

https://doi.org/10.1182/blood.V104.11.1379.1379

Published: 2004

Journal Articles

Effect of Age and Previous Autologous Transplant on Treatment-Related Mortality and GVHD in 140 Patients Treated with Reduce-Intensity Conditioning and Allograft for Advanced Hematological Malignancies.

Paolo Corradini, M.D., Francesco Zallio, M.D., Jacopo Mariotti, M.D., Pinuccia Valagussa, M.D., Anna Dodero, M.D., Marco Bregni, M.D., Fabio Ciceri, M.D., Andrea Bacigalupo, M.D., Moira Lucesole, M.D., Francesca Patriarca, M.D., Andrea Rambaldi, M.D., Rosanna Scimè, M.D., Giuseppe Bandini, M.D., Alessandro M. Gianni, M.D., Corrado Tarella, M.D., Attilio Olivieri, M.D.

Blood (2004) 104 (11): 5138.

https://doi.org/10.1182/blood.V104.11.5138.5138

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Identification of SETBP1 As an Epigenetic Hub Protein That Induces the Transcription of a Network of Development-Related Genes

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

Microarray of Bone Marrow CD34+/Lin- Cells from Patients with Chronic Myeloid Leukemia (CML)

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse of Malignant Disease: Retrospective Analysis of Outcome and Predictive Factors

Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality

Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT.

Matched Unrelated Donor Stem Cell Transplantation for Patients with Diffuse Large Cell B Cell Lymphoma: A Retrospective Analysis of 118 Patients Registered through the European Group for Blood and Marrow Transplantation (EBMT).

Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function

Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation (allo-SCT) Is an Effective Salvage Treatment for Peripheral T-Cell Non-Hodgkin’s Lymphoma (PTCL).

Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Stem Cell Transplantation (SCT) for Relapsed Lymphomas: Impact of Pre-Transplantation Factors on Long-Term Outcome.

Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.

A proportion of patients with lymphoma may harbor mutations of the perforin gene

Patients with Lymphoma May Harbor Mutations of the Perforin Gene.

Inherited Perforin and Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma.

Effect of Age and Previous Autologous Transplant on Treatment-Related Mortality and GVHD in 140 Patients Treated with Reduce-Intensity Conditioning and Allograft for Advanced Hematological Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only